πŸ‡ΊπŸ‡Έ FDA
Patent

US 11666557

Triazolone compounds and uses thereof

granted A61KA61K31/41A61K31/4196

Quick answer

US patent 11666557 (Triazolone compounds and uses thereof) held by TEMPEST THERAPEUTICS, INC. expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEMPEST THERAPEUTICS, INC.
Grant date
Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/41, A61K31/4196, A61K31/4439, A61K31/506